Category: Medosis Newsroom
-
On March 19, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to Keytruda (pembrolizumab), a leading immunotherapy developed by Merck,…
On March 19, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to Keytruda (pembrolizumab), a leading immunotherapy developed by Merck,…